Status:
COMPLETED
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
Observational, non-comparative, epidemiological study to collect and analyse real life data on schizophrenic patients receiving quetiapine according to the standard medical practice in Croatia. The ma...
Eligibility Criteria
Inclusion
- Patients with diagnosis of schizophrenia
- Patients who are already treated with quetiapine for at least 12 weeks (outpatients or hospitalised patients)
- Patients capable of signing ICF
Exclusion
- Patients with hypersensitivity to active substance or any of the excipients of this product
- Patients with contraindication for quetiapine therapy according to the approved SmPC
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00981123
Start Date
September 1 2009
End Date
April 1 2010
Last Update
January 10 2011
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Bjelovar, Croatia
2
Research Site
Čakovec, Croatia
3
Research Site
Dubrovnik, Croatia
4
Research Site
Karlovac, Croatia